Virtusa Partners with the Indiana Biosciences Research Institute (IBRI) to Drive Innovation and Accelerate Therapy Research

11/7/2018

SOUTHBOROUGH, Mass.--Virtusa Corporation (NASDAQ GS:VRTU), a global provider of digital strategy, digital engineering, and IT outsourcing services that accelerates business outcomes for its clients, today announced its collaboration with the Indiana Biosciences Research Institute (IBRI) to accelerate Life Sciences research and development. This partnership will leverage Virtusa’s vLife open innovation platform to enable organizations to work in a connected ecosystem that allows them to access, validate, and adopt other firms’ technologies (e.g. analytics, machine learning, artificial intelligence) and enhance the entire research and development process.

For more information, visit https://www.virtusa.com/news-room/press-releases/article/11540051425/

2019 Annual Report cover

The IBRI 2019 Annual Report is now available. The report theme is “Catalyze, Complement, Connect,” which correlates with the IBRI's goals to seek solutions for health problems, enhance the Indiana life sciences ecosystem, and expedite solutions for the most pressing health issues.